National Institutes of Health: all 11,571 studies

Page 44 of 116. Open to participants first (946), then studies with results posted, then the rest; newest registration first within each.

• Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV InfectionTerminatedNCT02134886Phase 1
• Sapanisertib Before and After Surgery in Treating Patients With Recurrent GlioblastomaTerminatedNCT02133183Phase 1
• The Genetic Basis of Acquired Heart Disease in AfricaCompletedNCT02124109
• Zoonotic Influenza Infections of Swine Origin at Ohio Agricultural FairsCompletedNCT02124096
• Therapeutic Effect of Recombinant Human Growth Hormone (rhGH) on the Myopathy of CystinosisWithdrawnNCT02124070Phase 1/2
• Study of Hepatic Function in Patients With Spinal and Bulbar Muscular AtrophyCompletedNCT02124057
• Effect of Fasting on the NLRP3 InflammasomeCompletedNCT02122575
• Effects of Transcranial Magnetic Stimulation (TMS) on Somatosensory PerceptionCompletedNCT02119637
• Neural Substrates of Approach-Avoidance ConflictCompletedNCT02119624
• Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995CompletedNCT02116764
• ADRN Barrier/Immunoprofiling Exploratory Pilot StudyCompletedNCT02115399
• Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV InfectionTerminatedNCT02109224Phase 1
• Characterization Imaging Instruments in Alcoholics and Non-AlcoholicsCompletedNCT02108080
• Behavioral and Functional Task Development, Implementation, and TestingCompletedNCT02108054Not applicable
• Personalized Medicine Decision-Making in a Virtual Clinical SettingCompletedNCT02108041
• Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With CancerCompletedNCT02108028
• Evaluation of a Novel Positron Emission Tomography (PET Radiotracer for TARP Gamma-8TerminatedNCT02108015Phase 1
• Effect of Vorinostat on Nervous System Hemangioblastomas in Von Hippel-Lindau Disease (Missense Mutation Only)CompletedNCT02108002Phase 1
• A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid TumorsCompletedNCT02107963Phase 1
• Depotentiation in People With Focal Hand DystoniaTerminatedNCT02106936
• Phase I Trial to Determine the Safety and Pharmacokinetics of CRS3123.CompletedNCT02106338Phase 1
• Wild-Type Reovirus in Combination With Carfilzomib and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT02101944Phase 1
• Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade GliomaCompletedNCT02101905Phase 1
• Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic SyndromeStatus unknownNCT02101138Phase 2
• Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Pediatric PopulationsCompletedNCT02100436Phase 2
• Virtual Reality Pain Control Orthopedic TraumaCompletedNCT02100163Not applicable
• Celecoxib in Preventing the Damaging Effects of Sunburn in Healthy VolunteersCompletedNCT02099136Phase 2
• Impact of TMP-SMX Prophylaxis on Malaria Infection and Immunity in Children in UgandaCompletedNCT02094508
• Screening Protocol to Evaluate Volunteers for NIA Approved StudiesCompletedNCT02091271
• Celecoxib in Decreasing the Damaging Effects of Sunburn in Healthy VolunteersCompletedNCT02090933Phase 2
• fMRI Neurofeedback for Motor RehabilitationTerminatedNCT02089776
• Auranofin PK Following Oral Dose AdministrationCompletedNCT02089048Phase 1
• Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995Status unknownNCT02082353
• Trametinib in Treating Patients With Advanced Cancer With or Without Hepatic DysfunctionCompletedNCT02070549Phase 1
• Imaging CXCR4 Expression in Subjects With Cancer Using 64 Cu-PlerixaforTerminatedNCT02069080Early Phase 1
• Patients Treated for Wiskott-Aldrich Syndrome (WAS) Since 1990CompletedNCT02064933
• Blood Collection From People With Ovarian CancerCompletedNCT02063464
• Hispanic Community Health Study / Study of LatinosActive, not recruitingNCT02060344
• Blood Collection From Healthy Volunteers and Patients for the Production of Clinical Grade Induced Pluripotent Stem Cell (iPSC) ProductsWithdrawnNCT02056613
• Study on Moebius Syndrome and Congenital Facial Weakness DisordersCompletedNCT02055248
• Study of Pain Processing in Experienced Yoga PractitionersCompletedNCT02055235
• Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung DiseaseCompletedNCT02055222
• Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African-Americans Study (GENE-FORECAST)CompletedNCT02055209
• Safety of Sublingual dmLT for ETECCompletedNCT02052934Phase 1
• Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch SyndromeCompletedNCT02052908Phase 1
• Validation of the Ask Suicide-Screening Questions (ASQ) in the Inpatient Medical SettingTerminatedNCT02050867
• Study of Variation Over Time in the Oral MicrobiomeCompletedNCT02049398
• Epacadostat Before Surgery in Treating Patients With Newly Diagnosed Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT02042430Early Phase 1
• Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and ChildrenCompletedNCT02040831Phase 1
• A Novel Compound for Alcoholism TreatmentCompletedNCT02039349Phase 1
• A Phase 1, Open Label, Ascending Dose Cohort Study of the Pharmacokinetics of Anti-Influenza Hyperimmune Intravenous Immunoglobulin in Healthy SubjectsWithdrawnNCT02037282Phase 1
• Pomalidomide After Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeCompletedNCT02029950Phase 1
• Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral TherapyCompletedNCT02028403Phase 1
• Treatment of SCID Due to ADA Deficiency With Autologous Transplantation of Cord Blood or Hematopoietic CD 34+ Cells After Addition of a Normal Human ADA cDNA by the EFS-ADA Lentiviral VectorCompletedNCT02022696Phase 1
• Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy AdultsCompletedNCT02021968Phase 1
• Study of the Effects of Blackcurrant Extract and Omega-3 Fats on the Health of the Heart and Blood VesselsWithdrawnNCT02019680
• An Investigation of the Biological and Neuronal Mechanisms of Post Traumatic Stress Disorder, Depression and Post-Concussive Syndrome Onset Following a Traumatic Brain InjuryCompletedNCT02019654
• Study to Evaluate the Natural History of Head and Neck Cancer Precursors in TaiwanCompletedNCT02017288
• Trametinib With or Without Whole Brain Radiation Therapy in Treating Patients With Brain MetastasesActive, not recruitingNCT02015117Phase 1
• Study of Controlled Human Malaria Infections to Evaluate Protection After Intravenous or Intramuscular Administration of PfSPZ Vaccine in Malaria-Naive AdultsCompletedNCT02015091Phase 1
• Black Family Eating Behaviors StudyCompletedNCT02015078
• Natural History and Tissue Acquisition Study of Adrenocortical CarcinomaCompletedNCT02015026
• Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)CompletedNCT02008578Phase 1
• Development of a Proxy Motor Outcome Measure in Young Children With Neuromuscular DiseaseTerminatedNCT02007213
• Safety and Immunogenicity of a Live Attenuated H7N9 Influenza Virus Vaccine in Healthy AdultsCompletedNCT01995695Phase 1
• Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy AdultsCompletedNCT01993706Phase 1
• Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant MelanomaActive, not recruitingNCT01989585Phase 1/2
• Booster Vaccination in Preventing Disease Recurrence in Previously Vaccinated Patients With Melanoma That Has Been Removed By SurgeryCompletedNCT01989559Phase 1
• Study of Safety and Immunogenicity of HIV Vaccines in Healthy VolunteersCompletedNCT01989533Phase 1
• Study of Safety and Effectiveness of Intravenous Immunization With PfSPZ Vaccine in Healthy African AdultsCompletedNCT01988636Phase 1
• The Contraceptive Choice ProjectStatus unknownNCT01986439
• Web-based Patient Reported Outcome Measurement Information System (PROMIS ) to Explore Burden and Stress in Cancer Caregivers (BaSiC2)CompletedNCT01981538
• A Pilot Study of Metformin in Patients With a Diagnosis of Li-Fraumeni SyndromeCompletedNCT01981525Phase 1
• Study of People With HIV Infection Who Have High Viral Loads Despite Combination Antiretroviral TherapyCompletedNCT01976715
• Multi-Level HIV Prevention for Pregnant Drug AbusersCompletedNCT01976702Not applicable
• Safety, Tolerability, Drug Interactions, and Antiviral Activity of Rilpivirine in Antiretroviral-Naive HIV-Infected Children Less Than 12 Years of AgeWithdrawnNCT01975012Phase 1/2
• A Retrospective Multicenter Study to Determine 5-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-01 StudyCompletedNCT01974999
• Functional Brain Imaging in Healthy Volunteers to Study Cognitive FunctionsCompletedNCT01974427
• Evaluating the Safety and Immune Response to Three Different Prime-Boost HIV Vaccine Regimens in Healthy, HIV-Uninfected AdultsWithdrawnNCT01970449Phase 1
• Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and ChildrenCompletedNCT01968083Phase 1
• Study of the Effect of a Very-Low-Carbohydrate Diet on Energy ExpenditureTerminatedNCT01967563
• Evaluating the Safety and Immune Response to Five Different Combinations of HIV Vaccines in Healthy, HIV-Uninfected AdultsWithdrawnNCT01964937Phase 1
• Evaluating a New Knee-Ankle-Foot Brace to Improve Gait in Children With Movement DisordersCompletedNCT01961557Not applicable
• Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin LymphomaActive, not recruitingNCT01955499Phase 1
• Participation in a Research Registry for Immune DisordersCompletedNCT01953016
• The Genetic Basis of Congenital Heart Disease in AfricaCompletedNCT01952171
• Point Prevalence Study of Multidrug-Resistant Organism Carriage by Healthcare PersonnelCompletedNCT01952158
• Hydroxyurea in Pulmonary Arterial HypertensionWithdrawnNCT01950585Early Phase 1
• Evaluation of Budesonide and How It Interacts With Antifungal Drugs in People With Gastrointestinal Graft-Versus-Host DiseaseTerminatedNCT01950507Phase 1
• Evaluation of Sickle Cell Liver DiseaseCompletedNCT01950429
• Imaging and Genetic Investigation of Learning and Decision MakingCompletedNCT01950377
• VRC 601: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to HIV-Infected...CompletedNCT01950325Phase 1
• The Pharmacokinetics of Extended Duration High-dose Cefixime for the Decreased Susceptibility of Neisseria Gonorrhoeae: A Phase I Pilot StudyCompletedNCT01949363Phase 1
• T and B Cell Responses in Autoimmune DiseasesTerminatedNCT01947036
• Dabrafenib and Lapatinib in Treating Patients With Refractory Thyroid Cancer That Cannot Be Removed by SurgeryActive, not recruitingNCT01947023Phase 1
• H7N9 Mix and Match With AS03 and MF59 in Healthy AdultsCompletedNCT01942265Phase 2
• Ipilimumab With or Without Dabrafenib, Trametinib, and/or Nivolumab in Treating Patients With Melanoma That Is Metastatic or Cannot Be Removed by SurgeryTerminatedNCT01940809Phase 1
• Effects of Exercise on Memory in Healthy and Brain-Injured IndividualsTerminatedNCT01939769Phase 1
• Genetic and Other Aspects of PodoconiosisTerminatedNCT01939431
• H7N9 Mix and Match With MF59 in Healthy AdultsCompletedNCT01938742Phase 2

← National Institutes of Health overview and focus areas